Ayahuasca Reverses Long-Term Effects of Early Stress in Rat Study

A single dose of ayahuasca mitigated anxiety- and depression-like behaviors and restored brain chemistry in rats exposed to early trauma, a new study reveals.

Dr. Mohammed Looti An academic and researcher specialized in
PUBLISHED
Scientifically Reviewed · Dr. Marwa Abd-Alazim · November 15, 2026
Medically & Scientifically Reviewed Verified: November 15, 2026
Dr. Marwa Abd-Alazim PhD in Psychology
Faculty Member • University of Kerbala
Review Criteria & Clinical Standards

This content undergoes rigorous scientific peer-review and medical editorial standards at Arab Psychology Network to ensure clinical accuracy, validity, and compliance with evidence-based guidelines from leading psychological and healthcare authorities (APA / WHO).

A single dose of the classic psychedelic brew ayahuasca can reverse long-standing behavioral and neurological abnormalities caused by early adversity, according to a recent rodent study published in the Journal of Neural Transmission. Investigating the lasting toll of childhood trauma, researchers discovered that administering the botanical mixture to adult rats mitigated enduring symptoms of anxiety and depression while restoring essential neurochemical balances in the brain.

A Single Dose Reverses Long-Term Behavioral Changes

Early developmental adversity is widely recognized as one of the strongest risk factors for developing psychiatric conditions in adulthood. In the study, rats subjected to early-life maternal deprivation developed profound, enduring depressive- and anxiety-like behaviors that persisted into their adult lives.

Remarkably, a single administration of ayahuasca significantly attenuated these behavioral impairments. The treated rodents exhibited substantial behavioral recovery compared to untreated peers. According to the research team, these therapeutic benefits remained evident at least 15 days after the single dose was administered, suggesting that the compound induces sustained functional changes that outlast its acute pharmacological window.

Restoring Brain Chemistry and Relieving Cellular Stress

Beneath the behavioral improvements, the study identified deep neurochemical repairs. Maternal deprivation caused marked reductions in dopamine, serotonin, and brain-derived neurotrophic factor (BDNF) across three key regions: the frontal cortex, the hippocampus, and the striatum.

Treatment with ayahuasca successfully replenished both monoamine transmitters and BDNF levels, bolstering critical mechanisms tied to neuroplasticity and mood regulation. Furthermore, early trauma triggered cellular damage in the form of elevated oxidative stress. Ayahuasca counteracted this stress by rebalancing the activities of essential antioxidant defense enzymes, including superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase.

How the Experiment Was Designed

To simulate early-life adversity, the investigators separated Wistar rat pups from their mothers for three hours per day during the first 10 days of life. Once the rodents reached maturity, the team deployed a comprehensive battery of behavioral assays: the elevated plus maze and the open field test to evaluate anxiety-like behaviors, along with the splash test and forced swim test to assess depressive-like states and motivational deficits.

To ensure the findings reflected genuine biological recovery rather than acute drug intoxication, the researchers waited 15 days after the single ayahuasca administration before examining the animals. Brain tissue from the frontal cortex, hippocampus, and striatum was then harvested to evaluate long-term monoamine concentrations, neurotrophic markers, and antioxidant enzyme activity.

Implications and the Road to Clinical Translation

The findings address a critical bottleneck in contemporary psychiatry. Conventional pharmacotherapies for major depressive disorder are often inadequate, with fewer than half of patients achieving sustained remission following a first-line treatment. In addition, existing medications frequently cause burdensome side effects, driving scientific interest toward serotonergic psychedelics that work through distinct neurological pathways.

While this rodent model demonstrates robust therapeutic potential for repairing trauma-induced deficits, the researchers caution that findings in animals cannot be immediately extrapolated to human health. Comprehensive translational research and controlled clinical trials will be necessary to establish the safety, tolerability, and clinical efficacy of ayahuasca-based therapies for patients living with major depressive disorder.


Source

  • Single ayahuasca administration mitigates long-term behavioral and neurochemical effects of early-life stress in rats
  • Researchers: Guilherme Lodetti, Henrique Redivo, Amanda Gomes Teixeira, Ana Caroline Salvador de Farias, Lucas de Oliveira Pacagnan, João Pedro Veronezi Rohling, Anna Thereza Endler, Elen Perego Zampronio
  • Journal: Journal of Neural Transmission
  • Read the original study

Rate This Content

Be the first to rate this

Cite This Article

Looti, M. (2026, November 15). Ayahuasca Reverses Long-Term Effects of Early Stress in Rat Study. ASHA PSYCHOLOGICAL DATABASE. https://ashadocs.org/?psych_news=ayahuasca-single-dose-early-life-stress-depression-rats
Looti, Mohammed. “Ayahuasca Reverses Long-Term Effects of Early Stress in Rat Study.” ASHA PSYCHOLOGICAL DATABASE, 15 November 2026, https://ashadocs.org/?psych_news=ayahuasca-single-dose-early-life-stress-depression-rats.
Looti, Mohammed. “Ayahuasca Reverses Long-Term Effects of Early Stress in Rat Study.” ASHA PSYCHOLOGICAL DATABASE. November 15, 2026. https://ashadocs.org/?psych_news=ayahuasca-single-dose-early-life-stress-depression-rats.